KHC
ALHC icon

Koesten Hirschmann & Crabtree’s Alignment Healthcare ALHC Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15
Closed -$262 – 47
2025
Q3 		$262 Hold
15
– – ﹤0.01% 233
2025
Q2 		$210 Hold
15
– – ﹤0.01% 311
2025
Q1 		$280 Hold
15
– – ﹤0.01% 196
2024
Q4 		$169 Hold
15
– – ﹤0.01% 189
2024
Q3 		$178 Hold
15
– – ﹤0.01% 189
2024
Q2 		$75 Hold
15
– – ﹤0.01% 216
2024
Q1 		$75 Hold
15
– – ﹤0.01% 216
2023
Q4 		$130 Hold
15
– – ﹤0.01% 177
2023
Q3 		$105 Hold
15
– – ﹤0.01% 174
2023
Q2 		$87 Hold
15
– – ﹤0.01% 162
2023
Q1 		$96 Hold
15
– – ﹤0.01% 248
2022
Q4 		$176 Buy
+15
New +$182 ﹤0.01% 153

Other funds holding ALHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Koesten Hirschmann & Crabtree's ALHC Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Alignment Healthcare (ALHC) in Q4 2025, closing a stake of 15 shares — an estimated $262 sold.

Koesten Hirschmann & Crabtree first reported a position in ALHC in Q4 2022 and held it in 12 quarters. The position peaked at $280 in Q1 2025. 263 funds tracked by Wall St. Rank hold ALHC as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Alignment Healthcare position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 15 Alignment Healthcare shares in Q4 2025, an estimated $262.
  • Koesten Hirschmann & Crabtree first reported a position in Alignment Healthcare in Q4 2022 and held it in 12 quarters.
  • Koesten Hirschmann & Crabtree's Alignment Healthcare position peaked at $280 in Q1 2025.
  • 263 funds tracked by Wall St. Rank held Alignment Healthcare as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.